Document is current
Any future updates will be listed below
-
Authors
Seo, Jaein https://orcid.org/0000-0001-6061-4301
Thomas, Caitlin https://orcid.org/0000-0002-2314-714X
Tervonen, Tommi https://orcid.org/0000-0001-7303-500X
Krucien, Nicolas https://orcid.org/0000-0001-9179-6558
Ford, Janet H. https://orcid.org/0000-0001-7966-7737
Stauffer, Virginia L.
Nicholson, Robert A.
Duffy, Kevin Harrison
Tockhorn-Heidenreich, Antje
-
Funding
Funding for this research was provided by:
Eli Lilly and Company
- License Information
-
More Information
Article History
Received: 8 April 2025
Accepted: 16 July 2025
First Online: 2 August 2025
Declarations
:
: Jaein Seo, Caitlin Thomas, and Nicolas Krucien are employees of Evidera, a business unit of PPD, which was contracted by Eli Lilly and Company for work related to this study. Jaein Seo holds stocks of Thermo Fisher. Tommi Tervonen was an employee of Evidera at time of this work and is currently an employee of Kielo Research, Switzerland. Antje Tockhorn-Heidenreich, Virginia Stauffer, Robert Nicholson, and Kevin Harrison Duffy are employees of Eli Lilly and Company, and own company stock. Janet Ford was an employee of Eli Lilly and Company at time of this work and is currently an employee of Agios Pharmaceuticals.
: The study was approved by Ethical & Independent (E&I) Review Services (E&I study number 20068-01 and 20068-01B for the modified survey following the quantitative pilot). The study was performed in accordance with the Helsinki Declaration of 1964 and its later amendments. All participants provided online consent to participate.
